Published in Br J Haematol on March 25, 2013
The fat cell epigenetic signature in post-obese women is characterized by global hypomethylation and differential DNA methylation of adipogenesis genes. Int J Obes (Lond) (2015) 0.88
CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation. Sci Rep (2014) 0.76
DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma. Cell Death Dis (2017) 0.75
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell (2006) 10.19
The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet (2013) 3.43
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet (2011) 3.41
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. Blood (2011) 2.66
Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling. J Biol Chem (2002) 1.97
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas. Proc Natl Acad Sci U S A (2008) 1.83
Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab (2009) 1.72
Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. J Immunol (2010) 1.28
An optimized algorithm for detecting and annotating regional differential methylation. BMC Bioinformatics (2013) 1.27
BMP4: its role in development of the hematopoietic system and potential as a hematopoietic growth factor. Stem Cells (2004) 1.18
The nucleotide-binding site of human sphingosine kinase 1. J Biol Chem (2002) 1.14
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone (2004) 1.06
Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1. PLoS Pathog (2010) 1.02
Molecular basis of cytokine receptor activation. IUBMB Life (2010) 1.01
Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML. Blood (2009) 0.97
Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit. Blood (2010) 0.97
Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells. Haematologica (2009) 0.97
Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95. Exp Hematol (2003) 0.97
Dynamic evolution of clonal epialleles revealed by methclone. Genome Biol (2014) 0.97
Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors. Proc Natl Acad Sci U S A (2012) 0.96
A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia. Leuk Lymphoma (2014) 0.96
The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J Bone Miner Res (2004) 0.96
Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription. Blood (2013) 0.94
The GM-CSF receptor family: mechanism of activation and implications for disease. Growth Factors (2012) 0.93
Development of CD4+CD25+FoxP3+ regulatory T cells from cord blood hematopoietic progenitor cells. J Leukoc Biol (2008) 0.92
Genetic regulators of myelopoiesis and leukemic signaling identified by gene profiling and linear modeling. J Leukoc Biol (2006) 0.92
Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma. Leuk Lymphoma (2006) 0.89
HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia. Oncotarget (2013) 0.89
Functional cross-talk between cytokine receptors revealed by activating mutations in the extracellular domain of the beta-subunit of the GM-CSF receptor. J Leukoc Biol (2002) 0.89
Signalling by the βc family of cytokines. Cytokine Growth Factor Rev (2013) 0.88
Clonal and lineage analysis of somatic DNMT3A and JAK2 mutations in a chronic phase polycythemia vera patient. Br J Haematol (2011) 0.87
The granulocyte-associated transcription factor Krüppel-like factor 5 is silenced by hypermethylation in acute myeloid leukemia. Leuk Res (2011) 0.86
Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engraftment in nonobese diabetic/severe combined immune deficient mice. Stem Cells (2009) 0.86
The preferential occurrence of FLT3-TKD mutations in inv(16) AML and impact on survival outcome: a combined analysis of 1053 core-binding factor AML patients. Br J Haematol (2012) 0.84
Bone morphogenetic protein 4 contributes to the maintenance of primitive cord blood hematopoietic progenitors in an ex vivo stroma-noncontact co-culture system. Stem Cells Dev (2006) 0.83
The vent-like homeobox gene VENTX promotes human myeloid differentiation and is highly expressed in acute myeloid leukemia. Proc Natl Acad Sci U S A (2010) 0.83
The double life of KLF5: Opposing roles in regulation of gene-expression, cellular function, and transformation. IUBMB Life (2013) 0.82
The epigenomics revolution in myelodysplasia: a clinico-pathological perspective. Pathology (2011) 0.82
Constitutive mutants of the GM-CSF receptor reveal multiple pathways leading to myeloid cell survival, proliferation, and granulocyte-macrophage differentiation. Blood (2003) 0.82
Protein kinase activity of phosphoinositide 3-kinase regulates cytokine-dependent cell survival. PLoS Biol (2013) 0.82
One-step Melt Synthesis of Water Soluble, Photoluminescent, Surface-Oxidized Silicon Nanoparticles for Cellular Imaging Applications. Chem Mater (2011) 0.81
p53-Dependent transcriptional responses to interleukin-3 signaling. PLoS One (2012) 0.81
Hematopoietic growth factor mimetics: from concept to clinic. Cytokine Growth Factor Rev (2009) 0.80
Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling. Cancer Res (2013) 0.80
Potential therapeutic applications of mesenchymal stromal cells. Pathology (2011) 0.80
The GM-CSF receptor utilizes β-catenin and Tcf4 to specify macrophage lineage differentiation. Differentiation (2011) 0.79
RUNX1 mutations are rare in chronic phase polycythaemia vera. Br J Haematol (2011) 0.79
Plasma levels of soluble interleukin 1 receptor accessory protein are reduced in obesity. J Clin Endocrinol Metab (2014) 0.79
Cooperation of cytokine signaling with chimeric transcription factors in leukemogenesis: PML-retinoic acid receptor alpha blocks growth factor-mediated differentiation. Mol Cell Biol (2003) 0.77
Post-transplant plasmablastic lymphoma of the skin. Australas J Dermatol (2012) 0.77
Potential for clinical ex vivo expansion of cord blood haemopoietic stem cells using non-haemopoietic factor supplements. Curr Stem Cell Res Ther (2007) 0.77
A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia. Br J Haematol (2014) 0.76
Vosaroxin is a novel topoisomerase-II inhibitor with efficacy in relapsed and refractory acute myeloid leukaemia. Expert Opin Pharmacother (2015) 0.76
Predicting Perioperative Transfusion in Elective Hip and Knee Arthroplasty: A Validated Predictive Model. Anesthesiology (2017) 0.75
Outcomes of lymphoma in South Australia, 1977-2007. Med J Aust (2012) 0.75
Mobilisation strategies for normal and malignant cells. Pathology (2011) 0.75
Genome-wide gene expression profiling identifies overlap with malignant adrenocortical tumours and novel mechanisms of inefficient steroidogenesis in familial ACTH-independent macronodular adrenal hyperplasia. Endocr Relat Cancer (2012) 0.75
Evaluating the efficacy of subcellular fractionation of blast cells using live cell labeling and 2D DIGE. Methods Mol Biol (2012) 0.75
New sequence-tagged site molecular markers for identification of sex in Distichlis spicata. Mol Ecol Resour (2009) 0.75
Unraveling the "known unknowns": lessons and reflections from the new directions in leukemia research 2012 conference. Cancer Res (2012) 0.75
Erratum to "Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study" [Biol Blood Marrow Transplant 2016;22:1410-1415]. Biol Blood Marrow Transplant (2016) 0.75
Cellular origin and lineage specificity of the JAK2(V617F) allele in polycythemia vera. Blood (2007) 0.75